NEW YORK (GenomeWeb News) – Caprotec Bioanalytics announced today that it has received a total of €6 million ($8.8 million) from two rounds of private financing to support further development and marketing of the firm’s Capture Compound Mass Spectrometry technology for analyzing complex protein mixtures.
 
Investors in the two rounds included Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and private investors including Heinrich-Maria Schulte, co-founder of Evotec and owner of the Wölbern Bank in Hamburg, Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.